Iron Overload (DBCOND0027984)

Identifiers

Synonyms
Iron Over Load / Acute iron intoxication / Iron overload / Iron overload (disorder) / Iron excess

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Deferoxamine
A chelating agent used to treat iron or aluminum toxicity and some blood transfusion dependent anemias.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06596746
Neurodegenerative Diseases Progression Markers (MARKERS-NDD)No drug interventionsNot AvailableNot Availablerecruiting
NCT00980421
Safety of Various Mode of Delivery of Iron Supplement on Iron Toxicity Markers in Preschool ChildrenNo drug interventionsprevention3unknown_status
NCT00138684
Cytochrome P450 2E1 and Iron OverloadNo drug interventionstreatment2completed
NCT06137079
"Iron Overload and Endocrinological Diseases"No drug interventionsNot AvailableNot Availablerecruiting
NCT02274233
Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemiatreatment1terminated
NCT02164253
Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patientssupportive_care2completed
NCT01516853
Non-invasive Quantification of Liver Iron With MRINo drug interventionsNot AvailableNot Availablecompleted
NCT02443545
Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemiastreatment4terminated
NCT04198545
Ethnic Differences in Iron Absorption (FeGenes)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01047098
Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of OxidationNo drug interventionsbasic_scienceNot Availablecompleted
NCT01342705
Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic CirrhosisNo drug interventionsprevention3terminated
NCT00800761
Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Majortreatment4completed
NCT02833493
Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron OverloadNo drug interventionsNot AvailableNot Availableunknown_status
NCT00117507
Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patientstreatment4completed
NCT04423237
Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCTNot AvailableNot Availablerecruiting
NCT00901199
Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overloadtreatment2completed
NCT02041299
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemiastreatment4terminated
NCT01395199
Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Majortreatment3completed
NCT00999349
Therapeutic Effects of Silymarin in Patients With B-thalassemia Majortreatment2 / 3unknown_status
NCT00401336
Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance ImagingNo drug interventionsdiagnosticNot Availablecompleted
NCT01927913
Treatment of Iron Overload Requiring Chelation Therapytreatment2withdrawn
NCT04631718
MRI QSM Imaging for Iron OverloadNo drug interventionsNot AvailableNot Availablecompleted
NCT01369719
Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron OverloadtreatmentNot Availablecompleted
NCT00005541
Hemochromatosis and Iron Overload Screening Study (HEIRS)No drug interventionsNot AvailableNot Availablecompleted
NCT01335035
Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overloadtreatment4completed
NCT01045525
Phlebotomy and Lifestyle and Diet Advices vs Lifestyle and Diet Advices Only in Patients With Dysmetabolic LiversiderosisNo drug interventionstreatment3completed
NCT02527330
Evaluation of Myocardial Iron Deposition in Patients of Heart Failure Using T2* MR ImagingNo drug interventionsNot AvailableNot Availablecompleted
NCT00512226
Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell ThalassemiaNo drug interventionsdiagnosticNot Availablecompleted
NCT05355766
Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded PatientsNo drug interventionstreatment2recruiting
NCT02474420
Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia PatientstreatmentNot Availableunknown_status
NCT00004982
Combination Iron Chelation Therapytreatment1completed
NCT01121094
Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* SequencesNo drug interventionsNot AvailableNot Availableunknown_status
NCT04515680
Endocrine Function During Deferasirox TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00654589
Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overloadtreatment4completed
NCT01159067
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overloadsupportive_care2terminated
NCT03800446
Validation of a Point-of-care Device Measuring Ferritin With Capillary BloodNo drug interventionsdiagnosticNot Availablewithdrawn
NCT00000595
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosistreatment2completed
NCT02155114
Iron Homoeostasis in InflammationNo drug interventionsNot AvailableNot Availablecompleted
NCT00001455
Iron Overload in African AmericansNo drug interventionsNot AvailableNot Availablecompleted
NCT06146608
Heme and Non-heme Iron Intakes, Gut Microbiota, and Influence on Host Iron AbsorptionNo drug interventionsNot AvailableNot Availablerecruiting
NCT00712738
Oral Nifedipine to Treat Iron Overloadtreatment1completed
NCT02025543
Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron ContentNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05326503
Inhibitory Effect of a Polyphenol Supplement on Dietary Iron Absorption in Adults With ThalassemiaNo drug interventionssupportive_careNot Availableunknown_status
NCT04614779
Long-term Clinical Study of CN128 in Thalassemia PatientsNo drug interventionstreatment2completed
NCT02880033
Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytesbasic_scienceNot Availablecompleted
NCT03141398
Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology GroupNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00293098
Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart DiseaseNot AvailableNot Availableapproved_for_marketing
NCT01874405
Retrospective Evaluation of Adult and Pediatric Transfusion-dependent Patients Treated With Deferasirox TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT03372083
Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosistreatment4completed
NCT00907283
Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)treatment2active_not_recruiting
NCT01169961
Assessment of Iron Deposition in Major Organs of Hemodialysis PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05294471
Fully Automated High-Throughput Quantitative MRI of the LiverNo drug interventionsNot AvailableNot Availablerecruiting
NCT00000588
Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl HydrazoneNo drug interventionstreatment2completed
NCT02425956
Non-invasive Quantification of Liver Iron With MRINo drug interventionsdiagnosticNot Availablecompleted
NCT04835285
MRI T2* Mapping of Myocardium, Liver, Pancreas and Pituitary GlandNo drug interventionsdiagnosticNot Availableunknown_status
NCT00806715
Iron Overload in Stem Cell Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01546415
Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic AnemiaNo drug interventionstreatment4completed
NCT00529152
Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patientstreatment3completed
NCT04018300
Iron Supplementation and Side EffectsNo drug interventionsbasic_scienceNot Availablecompleted
NCT03591575
Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Childrentreatment4completed
NCT04741542
Safety of SP-420 in the Treatment of Transfusional Iron Overloadtreatment1suspended
NCT01572818
Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload PatientsNo drug interventionstreatmentNot Availablecompleted
NCT00110617
Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patientstreatment2completed
NCT01572922
Massive Iron Deposit AssessmentNo drug interventionsdiagnosticNot Availablecompleted
NCT01376622
Changes in Pituitary Iron and Volume With DeferasiroxNo drug interventionsNot AvailableNot Availablecompleted
NCT00110266
Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patientstreatment2completed
NCT01905774
Renal Function Among Thalassemia Patients Treated by a Oral Chelator DeferasiroxNot AvailableNot Availablecompleted
NCT00689182
Safety and Efficacy of Iron Reduction by PhlebotomyNo drug interventionstreatment2completed
NCT00447694
Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatmenttreatment2completed
NCT00629291
MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.No drug interventionsNot AvailableNot Availablecompleted
NCT00395629
Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosistreatment1 / 2completed
NCT03801889
SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemiastreatment2withdrawn
NCT00171301
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)treatment4completed
NCT03777904
The Iron Content of Ferritin in Serum and Urine of Children With High Serum Ferritin LevelsNo drug interventionsNot AvailableNot Availableterminated
NCT01034072
Iron Overload in Pediatric Oncology PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00378469
Study of the Effects of Muscular Activity on Iron MetabolismNo drug interventionsNot AvailableNot Availableunknown_status
NCT00602446
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplantsupportive_care2terminated
NCT03990181
Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol SupplementNo drug interventionsbasic_scienceNot Availablecompleted
NCT01443195
Iron Metabolism in Small Pre Term NewbornspreventionNot Availableunknown_status
NCT04292314
Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemiatreatment2 / 3completed
NCT00000623
Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)Not AvailableNot Availablecompleted